Literature DB >> 16709858

Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.

Melody G Duvall1, Assan Jaye, Tao Dong, Jason M Brenchley, Abraham S Alabi, David J Jeffries, Marianne van der Sande, Toyin O Togun, Samuel J McConkey, Daniel C Douek, Andrew J McMichael, Hilton C Whittle, Richard A Koup, Sarah L Rowland-Jones.   

Abstract

Unlike HIV-1-infected people, most HIV-2-infected subjects maintain a healthy CD4+ T cell count and a strong HIV-specific CD4+ T cell response. To define the cellular immunological correlates of good prognosis in HIV-2 infection, we conducted a cross-sectional study of HIV Gag-specific T cell function in HIV-1- and HIV-2-infected Gambians. Using cytokine flow cytometry and lymphoproliferation assays, we show that HIV-specific CD4+ T cells from HIV-2-infected individuals maintained proliferative capacity, were not terminally differentiated (CD57-), and more frequently produced IFN-gamma or IL-2 than CD4+ T cells from HIV-1-infected donors. Polyfunctional (IFN-gamma+/IL-2+) HIV-specific CD4+ T cells were found exclusively in HIV-2+ donors. The disparity in CD4+ T cell responses between asymptomatic HIV-1- and HIV-2-infected subjects was not associated with differences in the proliferative capacity of HIV-specific CD8+ T cells. This study demonstrates that HIV-2-infected donors have a well-preserved and functionally heterogeneous HIV-specific memory CD4+ T cell response that is associated with delayed disease progression in the majority of infected people.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709858     DOI: 10.4049/jimmunol.176.11.6973

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients.

Authors:  Helena Skar; Pedro Borrego; Timothy C Wallstrom; Mattias Mild; José Maria Marcelino; Helena Barroso; Nuno Taveira; Thomas Leitner; Jan Albert
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

2.  HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.

Authors:  Caroline M Royle; David R Graham; Simone Sharma; Dietmar Fuchs; Adriano Boasso
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

3.  Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa.

Authors:  Natalie N Zheng; M Juliana McElrath; Papa Salif Sow; Andrew Mesher; Stephen E Hawes; Joshua Stern; Geoffrey S Gottlieb; Stephen C De Rosa; Nancy B Kiviat
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

4.  Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

Authors:  A B B Macedo; J C Sánchez-Arcila; A O Schubach; S C F Mendonça; A Marins-Dos-Santos; M de Fatima Madeira; T Gagini; M I F Pimentel; P M De Luca
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.

Authors:  Charani Ranasinghe; Fiona Eyers; John Stambas; David B Boyle; Ian A Ramshaw; Alistair J Ramsay
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

6.  Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.

Authors:  Mathias Lichterfeld; Rajesh T Gandhi; Rachel P Simmons; Theresa Flynn; Amy Sbrolla; Xu G Yu; Nesli Basgoz; Stanley Mui; Katie Williams; Hendrik Streeck; Nicole Burgett-Yandow; Gilbert Roy; Michel Janssens; Louise Pedneault; Pierre Vandepapelière; Marguerite Koutsoukos; Marie-Ange Demoitié; Patricia Bourguignon; Lisa McNally; Gerald Voss; Marcus Altfeld
Journal:  J Acquir Immune Defic Syndr       Date:  2012-01-01       Impact factor: 3.731

7.  Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.

Authors:  Wim Jennes; Makhtar Camara; Tandakha Dièye; Souleymane Mboup; Luc Kestens
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

Review 8.  The T-cell response to HIV.

Authors:  Bruce Walker; Andrew McMichael
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

9.  Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.

Authors:  Melody G Duvall; Karin Loré; Hetty Blaak; David A Ambrozak; William C Adams; Kathlyn Santos; Christof Geldmacher; John R Mascola; Andrew J McMichael; Assan Jaye; Hilton C Whittle; Sarah L Rowland-Jones; Richard A Koup
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants.

Authors:  David J C Miles; Louis Gadama; Anita Gumbi; Flora Nyalo; Bonus Makanani; Robert S Heyderman
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.